Physician profile
Brian E Ellis
NPI 1124038047
$2,247.32
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,863 · 2020: $160 · 2023: $51.62 · 2024: $173.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $140 · Food and Beverage: $84.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $140.00 |
| Food and Beverage | $84.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $296.85 | 2019-2020 | |
| Pfizer INC. | $284.74 | 2019-2020 | |
| Amgen INC. | $265.23 | 2019 | |
| Janssen Pharmaceuticals, INC | $216.59 | 2019-2024 | Xarelto |
| Supernus Pharmaceuticals, INC. | $163.94 | 2019 | |
| Novo Nordisk INC | $140.50 | 2019-2020 | |
| Medtronic, INC. | $140.00 | 2024 | |
| Merck Sharp & Dohme LLC | $132.23 | 2019 | |
| Glaxosmithkline, LLC. | $108.51 | 2019 | |
| Sunovion Pharmaceuticals INC. | $105.77 | 2019 | |
| Amarin Pharma, INC. | $95.22 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $75.50 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $52.46 | 2019-2020 | |
| Astellas Pharma US INC | $45.58 | 2019 | |
| Novartis Pharmaceuticals Corporation | $35.37 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $27.20 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $26.78 | 2019 | |
| Lilly USA, LLC | $23.05 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $11.80 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Ellis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.